VETIGEL
Commercial- Indications
- Veterinary bleeding control
Company intelligence / Profile preview
Cresilon
Brooklyn, New York, United Statesengineering.nyu.edu ↗
- Ownership
- Private
- Employees
- ~80
- Development stage
- Commercial
01
Overview
VETIGEL® has been commercially available since 2021 and widely adopted by veterinary surgeons globally. In June 2023, the company received its first FDA clearance for a human-use product—Cresilon Hemostatic Gel™ (“CHG™”)—for local management of minor bleeding wounds. The company plans to launch TRAUMAGEL® targeting moderate to severe external bleeding in humans. No clinical trial data are publicly detailed; regulatory clearance supports safety and efficacy claims.
- Therapeutic areas
- DermatologyHematology
- Modalities
- Device (Hemostatic gel)Hydrogel-based drug delivery therapy
- Industry
- Consumable Medical Devices
02
Drug pipeline
2 assets1 more asset in the full pipeline.
Request access →03
Partnerships
Not specified publicly as of June 2025. Strategic partnerships referenced but not named.
Beyond the preview
Go deeper on Cresilon.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Cresilon.